Recent Publications

✱Open Access

2024

• ✱Yang S, Huang S, Hincapie-Castillo JM, Ke X, Ding H, Schelfhout J, Sher M, Jones B, Wilson D, Lo-Ciganic W. Characteristics of US Medicare beneficiaries with chronic cough vs. non-chronic cough. J Clin Med. 2024;13(15):4549.

• ✱Wang H, Hincapie-Castillo JM, Gellad W, Jones B, Shorr R, Yang S, Wilson D, Lee J, Reisfield G, Kwoh C, Delcher C, Nguyen K, Harle C, Marcum Z, Lo-Ciganic W. Association between opioid-benzodiazepine trajectories and injurious fall risk among US Medicare beneficiaries. J Clin Med. 2024; 13(12):3376

• Chang C, Jones B, Hincapie-Castillo JM, Park H, Heldermon C, Diaby V, Wilson D, Lo-Ciganic W. Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors. Br J Cancer. 2024. doi:10.1038/s41416-024-02680-0

• Chang C, Jones B, Hincapie-Castillo JM, Park H, Heldermon C, Diaby V, Wilson D, Lo-Ciganic W. The association between trajectories of prescription opioid use and the risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors in the United States. Breast Cancer Res Treat. 2024;204(3):561-577

• ✱Beltran T, Lett E, Poteat T, Hincapie-Castillo JM. Computational Phenotyping within Electronic Healthcare Data to Identify Transgender People in the United States: A Narrative Review. Pharmacoepidemiol Drug Saf. 2024;33(3):e5732

• Dickinson H, Teltsch D, Feifel J, Hunt P, Vallejo-Yague E, Virkud A, Muylle K, Ochi T, Donneyong M, Zabinski J, Strauss V, Hincapie-Castillo JM. The unseen hand: AI-based prescribing decision support tools and the evaluation of medicine safety and effectiveness in the real world. Drug Saf. 2024;47(2):117-123.

• Figgatt MC, Hincapie-Castillo JM, Schranz AJ, Dasgupta N, Edwards JK, Jackson BE, Marshall SW, Golightly YM. Medications for opioid use disorder and mortality and hospitalization among people with opioid use-related infections. Epidemiology. 2023;10.1097/EDE.0000000000001681.

2023

• Figgatt MC, Schranz AJ, Jackson B, Dasgupta N, Hincapie-Castillo JM, Baggett C, Marshall SW, Golightly YM. Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses. Ann Epidemiol. 2023;S1047-2797(23)00168-0.

• ✱Yang S, Huang S, Hincapie-Castillo JM, Ke X, Ding H, Schelfhout J, Sher MR, Jones B, Wilson DL, Lo-Ciganic WH. Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012-2021. J Clin Med. 2023;12(19):6286.

• Keshwani S, Smith SM, Brown J, Lo-Ciganic WH, Yang S, Smolinski NE, Hincapie-Castillo JM. Trends in Prescribing of Non-Steroidal Anti-Inflammatory Medications in the US Ambulatory Care Setting from 2006-2016. J Pain. 2023;S1526-5900(23)00442-X. doi:10.1016/j.jpain.2023.06.008

• Hincapie-Castillo JM, Jonsson Funk M.  Mifepristone and the courts: The thread that could unravel regulation of drugs in the United States. Pharmacoepidemiol Drug Saf. 2023;10.1002/pds.5642. doi.org/10.1002/pds.5642

• Hincapie-Castillo JM, Unigwe I, Goodin A, Vouri S. Enhancing Active Learning of Medication Errors in the PharmD Curriculum through a Multi-perspective Experience. Curr Pharm Teach Learn. 2023. doi.org/10.1016/j.cptl.2023.03.009

• Chang C, Park H, Hincapie-Castillo JM, Heldermon C, Diaby V, Yang S, Wilson D, Lo-Ciganic W. Trends, characteristics, race and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression. J Manag Care Spec Pharm. 2023;29(4):431-445

• Hincapie-Castillo JM, Deravi M, Vouri S, Goodin A. Pragmatic Model and Faculty Toolkit for PharmD Student Engagement in Social and Administrative Pharmacy Research." American Journal of Pharmaceutical Education. 2023. doi.org/10.1016/j.ajpe.2023.02.006

• Hincapie-Castillo JM, Goodin A. Using Joinpoint Regression for Drug Utilization Research: Tutorial and Case Study of Prescription Opioid Use in the United States. Pharmacoepidemiol Drug Saf. 2023 Feb 22;. doi: 10.1002/pds.5606.

• ✱Figgatt M, Schranz A, Hincapie-Castillo JM, Golightly Y, Marshall S, Dasgupta N. Complications in Using Real World Data to Study the Health of People Who Use Drugs. Epidemiology. 2022. DOI: 10.1097/EDE.0000000000001564

2022

• ✱Jang HR, Quinones-Marrero J, Hincapie-Castillo JM. Environmental scan of COVID-19 infection dashboards in the Florida public school system. Front Public Health. 2022; DOI:10.3389/fpubh.2022.925808

• ✱ Keshwani S, Maguire M, Goodin A, Lo-Ciganic W, Wilson D, Hincapie-Castillo JM. Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in Two State Medicaid Programs. JAMA Health Forum. 2022;3(6):e221757. doi:10.1001/jamahealthforum.2022.1757

• ✱Yang S, Hincapie-Castillo JM, Ke X, Schelfhout J, Ding H, Sher M, Zhou L, Chang C, Wilson D, Lo-Ciganic W. Evaluation of Patterns of Cough Medication Use in Ambulatory Care Settings in the United States: 2003-2018. J. Clin. Med. 2022;11(13):3671. doi.org/10.3390/jcm11133671

• Park H, Desai R, Liu X, Smith SM, Hincapie-Castillo J, Henry L, Goodin A, Gopal S, Pepine CJ, Mohandas R. Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis. Clin J Am Soc Nephrol. 2022 May 19;. doi: 10.2215/CJN.14361121.

• Shen Y, Hincapie-Castillo JM, Vouri S, Dewar M, Sumfest J, Goodin A. Prescription Patterns of Adjuvant Pain Medications Following Opioid Supply Restriction Law in Florida: An Interrupted Time Series Analysis. Medical Care. 2022. doi: 10.1097/MLR.0000000000001719

• Lo-Ciganic WH, Hincapie-Castillo JM, Wang T, Ge Y, Jones BL, Huang JL, Chang CY, Wilson DL, Lee JK, Reisfield GM, Kwoh CK, Delcher C, Nguyen KA, Zhou L, Shorr RI, Guo J, Marcum ZA, Harle CA, Park H, Winterstein A, Yang S, Huang PL, Adkins L, Gellad WF. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: Group-based multi-trajectory models. Addiction. 2022 Feb 28;. doi: 10.1111/add.15857.

• ✱Yang S, Orlova Y, Lipe A, Boren M, Hincapie-Castillo JM, Park H, Chang C, Wilson D, Adkins L, Lo-Ciganic W. Trends in the Management of Primary Headaches in US Emergency Departments: Analysis of 2007-2018 National Hospital Ambulatory Medical Care Survey Data. J Clin Med 2022; 11(5): 1401. doi.org/10.3390/jcm11051401

• Hincapie-Castillo JM, Nicholson K, Baker T. Reducing Health Disparities Through Achieving Pharmacoequity. JAMA. 2022;327(6):589–590. doi:10.1001/jama.2021.24519

2021

• ✱Unigwe I, Yang S, Song HJ, Lo-Ciganic WH, Hincapie-Castillo JM, Cook RL, Park H. Trends in Sexually Transmitted Infections in United States Ambulatory Care Clinics from 2005-2016. J Clin Med. 2021 Dec 24;11(1):71. doi.org/10.3390/jcm11010071

• Oueini R, Goodin A, Hincapie-Castillo JM, Vouri S. Co-utilization of opioids and non-benzodiazepine hypnotic drugs in US ambulatory care visits, 2006-2016. J Am Pharm Assoc. 2021 Oct 22:S1544-3191(21)00438-6. PMID: 34799261

• ✱Shen Y, Hincapie-Castillo JM, Vouri SM, Dewar MA, Sumfest JM, Goodin AJ. Chronic Opioid Therapy Utilization Following an Acute Pain Prescription Supply Restriction Law: An Interrupted Time Series Analysis. Pain Physician. 2021 Sep;24(6):417-424. PMID: 34554682

• ✱Goodin A, Hincapie-Castillo JM. A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness. Lancet Reg Health Am. 2021. https://doi.org/10.1016/j.lana.2021.100075

• Valdes I, Possinger M, Hincapie-Castillo JM, Goodin A, Dewar M, Sumfest J, Vouri SM. Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law. J Gen Intern Med. 2021 Jul 8. doi: 10.1007/s11606-021-06966-4. PMID: 34236602

• ✱Keshwani S, Grande I, Maguire M, Vouri S, Goodin A, Hincapie-Castillo JM. The effects of the Florida’s Opioid Restriction Law for Acute Pain on the Utilization of Prescription NSAID Medications. JAMA Netw Open. 2021;4(6):e2113383. PMID: 34115125

• Goodin A, Hincapie-Castillo JM, Brown J, Roussos-Ross K. A Survey Assessment of Clinician Perceptions of Opioid Supply and Monitoring Requirement Policy Changes. J Opioid Manag. 2021;17(4):337-342

• Oueini R, Goodin A, Vouri SM, Lo-Ciganic W, Park H, Hincapie-Castillo JM. Changes in Schedule II Oral Opioid Volume Dispensed in a Private Payer Following Florida’s Acute Pain Opioid Restriction Law. J Manag Care Spec Pharm. 2021;27(6):779-784. PMID: 34057389

• Tran PT, Antonelli P, Hincapie-Castillo JM, Winterstein A. Effects of Food and Drug Administration Removal of Indications for Use of Oral Quinolones. JAMA Intern Med. 2021;181(6):808-816. PMID: 33871571

• ✱Albogami Y, Sarayani A, Hincapie-Castillo JM, Winterstein AG. Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015. Drug Saf. 2021;44(4):447-454 PMID: 33683646

• ✱Jugl S, Okpeku A, Costales B, Morris E, Alipour-Haris G, Hincapie-Castillo JM, Stetten N, Sajdeya R, Keshwani S, Joseph V, Zhang Y, Shen Y, Adkins L, Goodin A. A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the United States from 2016 to 2019. Med Cannabis Cannabinoid. 2021. DOI: 10.1159/000515069

• ✱Hincapie-Castillo JM, Easey T, Hernandez C, Goodin A, Usmani S, Vouri S. Changes in Quantity of Opioids Dispensed Following Florida’s Restriction Law for Acute Pain Prescriptions. Pain Med. 2021 Jan 27;. doi: 10.1093/pm/pnab017. [Epub ahead of print] PMID: 33502536

2020

• Hong Y, Xie Z, Gutter M, Odedina F, Hincapie-Castillo JM. Purchasing Drugs Abroad among US Cancer Survivors: Analysis of National Health Interview Survey 2011-2018. Am J Prev Med. 2020 Dec 24:S0749-3797(20)30511-0. PMID: 33358718

•  Shen Y, Bhagwandass H, Branchcomb T, Galvez S, Grande I, Lessing J, Mollanazar M, Ourhaan N, Oueini R, Sasser M, Valdes I, Jadubans A, Hollman J, Maguire M, Usmani S, Vouri S, Hincapie-Castillo JM, Adkins L, Goodin A. Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions. J Pain. 2021; 22(3):246-262. PMID: 33031943

• Usmani S, Hollman J, Adkins A, Ourhaan N, Oueini R, Bhagwandass H,  Goodin A, Hincapie-Castillo JM, Vouri S. Effects of Hydrocodone Rescheduling on Opioid Prescribing Outcomes: Systematic Review. J Am Pharm Assoc. 2021;61(2):e20-e44. PMID: 33127312

• Brokenshire S, Lemon SJ, Staley B, Voils A, Hincapie-Castillo JM. Impact of Injectable Opioid Restrictions during a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization. Pain Med. 2021;22(1):203-211. PMID: 32875327

• ✱Hong Y, Hincapie-Castillo JM, Xie Z, Segal S, Mainous A. Socioeconomic and Demographic Characteristics of Americans who purchase Prescription Drugs Outside the United States. JAMA Netw Open. 2020;3(6):e208968. PMID: 32579194

• ✱Hincapie-Castillo JM, Goodin A, Possinger M, Usmani S, Vouri S. Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions. JAMA Netw Open. 2020;3(2):e200234. PMID: 32108887

• Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback B, Winterstein AG. Comparative Effectiveness of Risk Mitigation Strategies to Prevent Fetal Exposure to Mycophenolate. BMJ Qual Saf. 2020;29(8):636-644. PMID: 31649165